New Delhi metallo-β-lactamase-1 (NDM-1) is a recently identified metallo-β-lactamase that
confers resistance to carbapenems and all other β-lactam antibiotics, with the exception of …

The advent of New Delhi metallo-β-lactamase-1 (NDM-1) as a new mechanism of microbial
resistance went mostly unmarked, despite it being plasmidmediated, highly transferable and …

New Delhi metallo-β-lactmase-1 (NDM-1) has recently emerged as a global threat because
of its ability to confer resistance to almost all clinically used β-lactam antibiotics, its presence …

During the past decade the increase of antibiotic resistance in Enterobacteriaceae has
become a major concern worldwide. Although beta-lactams have been widely used as the …

The New Delhi metallo-β-lactamase gene (bla NDM-1) has emerged as a worldwide
concern among isolates of Enterobacteriaceae. Its epidemiology is been strongly associated …

Objectives This study characterized a new variant of the New Delhi metallo-β-lactamase
(NDM). Methods A multidrug-resistant Escherichia coli isolate was recovered from the …

Objectives To investigate the β-lactamase background of ertapenem non-susceptible
isolates for the presence of the most commonly detected carbapenemase genes, bla KPC …

Since the first New Delhi metallo-beta-lactamase (NDM) report in 2009, NDM has spread
globally causing various types of infections. NDM-positive organisms produce in vitro …

Infections with carbapenem-resistant Enterobacteriaceae, particularly Klebsiella
pneumoniae, is emerging as an important challenge in healthcare settings worldwide. 1 …

Abstract Background: New Delhi metallo-β-lactamase-1 (NDM-1) is a relatively recent
carbapenemase enzyme that inactivates all β-lactam antibiotics with the exception of …